Governor Abbott Appoints Siewert to Texas Medical Board District Three Review Committee

Community NewsNews
156

Listen to article (english)

Translate to Spanish or other 102 languages!

Governor Greg Abbott appointed Rick Siewert, D.O. to the Texas Medical Board (TMB) District Three Review Committee for a term set to expire on January 15, 2030.
Governor Greg Abbott appointed Rick Siewert, D.O. to the Texas Medical Board (TMB) District Three Review Committee for a term set to expire on January 15, 2030. Image: ochiltreehospital.com 

Mega Doctor News

- Advertisement -

AUSTIN – Governor Greg Abbott appointed Rick Siewert, D.O. to the Texas Medical Board (TMB) District Three Review Committee for a term set to expire on January 15, 2030.

Rick Siewert, D.O. of Amarillo, is a self-employed physician with 43 years of experience in rural family practice and emergency room medicine. He is a member of the Texas Osteopathic Medical Association, an aviation medical examiner with the Federal Aviation Administration, and a medical examiner with the Federal Motor Carrier Safety Administration – Department of Transportation. Siewert received an Associate of Science in Pre-Medical from Amarillo College, a Bachelor of Science in Biology from the University of Houston, and a Doctor of Osteopathic Medicine from Kansas City College of Osteopathic Medicine.

Inflation source: Office of Governor Abbott

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Insomnia Linked to a Higher Risk of Stroke
Next article
Texas AG Investigates BCBS Over Medical Care Delays

More Articles

DHR Health Expands Kidney Transplant Program with Transplant Nephrologist, Dr. Victor E. Prado

As part of its ongoing commitment to bringing world-class healthcare to the Rio Grande Valley, DHR Health is pleased to announce the addition of double board-certified transplant nephrologist, Dr. Victor E. Prado. Dr. Prado will provide care to patients at DHR Health’s Transplant Institute,

New Therapy for Head and Neck Squamous Cell Carcinoma Receives Accelerated FDA Approval

The U.S. Food and Drug Administration today granted accelerated approval to Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) for the treatment of adults with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) whose disease has progressed on or after platinum-based chemotherapy and immunotherapy.

DHR Health to Host 13th Annual Circle of Care Caregivers Conference

DHR Health Rehabilitation Hospital will host its 13th Annual Circle of Care Caregivers Conference on Saturday, November 7, 2026, at the Edinburg Conference Center at Renaissance, offering educational presentations and resources for individuals caring for family members and loved ones.

HHS Opens $1 Million Funding Opportunity to Strengthen Women’s Preventive Care

The U.S. Department of Health and Human Services (HHS), through the Health Resources and Services Administration (HRSA), announced a Notice of Funding Opportunity (NOFO) for the Women’s Initiative for Screening and Health (WISH) program.
- Advertisement -